Medical research implants.

Ended Awarded Last action

Contract number
HT009025FG1210017
Awardee
Awarding agency
Obligated
$23,697

Award facts

Contract value 100% obligated
$23,697.13 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
339113 Surgical Appliance and Supplies Manufacturing
PSC
AN23 Health R&D Services; Health Research And Training; Experimental Development
Set-aside
No set-aside
Competition
1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Mounds View, MN 55112, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded a $23,697.13 firm fixed-price call order to Harvard Bioscience Inc. (operating as Data Sciences International) on December 5, 2024, for medical research implants, with performance scheduled to conclude by September 30, 2025. This contract call is issued under Harvard Bioscience's existing $4.8 million single-award Blanket Purchase Agreement with the Defense Health Agency, which was established on May 4, 2022, and remains active through May 3, 2027. The BPA serves as an indefinite delivery vehicle enabling the Defense Health Agency, Army Medical Command, and other military health system partners to efficiently procure specialized biomedical research solutions. Harvard Bioscience, a self-certified small disadvantaged business headquartered in New Brighton, Minnesota, operates through its Data Sciences International division and specializes in manufacturing wireless implantable telemetry transmitters, physiological monitoring systems, and related research instrumentation for preclinical studies.

Harvard Bioscience's contract portfolio under the DHA BPA encompasses telemetry acquisition equipment, pre-implanted research animals with telemetry devices, hardware and software systems, data analysis services, equipment refurbishment and calibration, and surgical implantation procedures. The company maintains performance locations in Mounds View, Minnesota; Aberdeen Proving Ground, Maryland; San Antonio, Texas; and Frederick, Maryland. As of the award date, task orders issued under this BPA have generated cumulative procurement value exceeding $1.5 million, with individual call orders typically ranging from approximately $8,320 to $235,556. No set-aside designation was applied to this particular call order. Harvard Bioscience has demonstrated extensive federal contracting experience across multiple agencies including the National Institutes of Health, Department of Veterans Affairs, Environmental Protection Agency, Food and Drug Administration, and Department of Agriculture.

Quick answers

Who was awarded contract HT009025FG1210017?

HT009025FG1210017 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on December 5, 2024.

How much is contract HT009025FG1210017 worth?

The government has obligated $23,697 on HT009025FG1210017.

Is contract HT009025FG1210017 an order under another contract?

Yes. HT009025FG1210017 is a BPA call under W81XWH22A0001, a blanket purchase agreement.

Was contract HT009025FG1210017 competed?

The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award